BALDONI, Monia
 Distribuzione geografica
Continente #
NA - Nord America 875
EU - Europa 732
AS - Asia 284
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 1.899
Nazione #
US - Stati Uniti d'America 872
SE - Svezia 164
IE - Irlanda 154
SG - Singapore 138
UA - Ucraina 121
IT - Italia 120
CN - Cina 44
VN - Vietnam 44
DE - Germania 40
HK - Hong Kong 40
FI - Finlandia 34
RU - Federazione Russa 25
GB - Regno Unito 17
BE - Belgio 12
RO - Romania 11
NL - Olanda 10
FR - Francia 6
IN - India 6
AT - Austria 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EU - Europa 3
KR - Corea 3
PL - Polonia 3
BR - Brasile 2
CA - Canada 2
JP - Giappone 2
TR - Turchia 2
UZ - Uzbekistan 2
BG - Bulgaria 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
Totale 1.899
Città #
Chandler 187
Dublin 154
Singapore 114
San Mateo 72
Ann Arbor 61
Jacksonville 56
Perugia 52
Boardman 46
Dong Ket 44
Hong Kong 40
Santa Clara 39
Altamura 36
Medford 35
Princeton 35
Wilmington 32
Andover 31
Lawrence 25
Beijing 24
Woodbridge 24
Ashburn 16
Brussels 12
Bucharest 11
Los Angeles 9
Saint Petersburg 9
Helsinki 8
San Paolo di Civitate 7
New York 6
Redwood City 6
Dallas 5
Den Haag 5
Norwalk 5
Redmond 5
Chicago 4
Shanghai 4
Amsterdam 3
Auburn Hills 3
Des Moines 3
Milan 3
Seoul 3
Falls Church 2
Houston 2
Izmir 2
Pune 2
Radeberg 2
Shillong 2
Tokyo 2
Abidjan 1
Almaty 1
Baotou 1
Caserta 1
Chaoyang 1
Chengdu 1
Clearwater 1
Cormeilles-en-Parisis 1
Dearborn 1
Delhi 1
Esslingen am Neckar 1
Florence 1
Florianópolis 1
Frankfurt Am Main 1
Fremont 1
Guangzhou 1
Handan 1
Jinan 1
Landshut 1
Manila 1
Moscow 1
Munich 1
Newark 1
Rabat 1
Riga 1
Rome 1
Seattle 1
Sofia 1
Tappahannock 1
Toronto 1
Xi'an 1
Zagreb 1
Totale 1.280
Nome #
GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice 96
IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut 96
Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. 87
Administration of isoflavones enriched pasta reduces gastric emptying time in healthy volunteers 85
Cooperation between Aspirin-triggered lipoxin and nitric oxide (NO) mediates anti-adhesive properties of NCX-4016 (NO-aspirin) on neutrophil-endothelial cell adherence. 81
PAR-2 modulates pepsinogen secretion from gastric-isolated chief cells. 79
Ultrasonographic assessment of colonic wall in moderate-severe ulcerative colitis: comparison with endoscopic findings 79
Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs. 77
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 76
A simplified method for anal ultrasonography: preliminary report 68
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 66
A new aminoacid derivative of ursodeoxycholate, N-L-glutamyl-UDCA (UDCA-glu) to release selectively UDCA in the rat colon. 61
Sonographic diagnosis of benign pneumoretroperitoneum following colonoscopy in Crohn's disease 58
Genomic and non-genomic effects of different glucocorticoids on mouse thymocyte apoptosis 56
Intestinal superinfections in patients wsith inflammatory bowel diseases 53
Colonic motility in ulcerative colitis 51
Soy germ-enriched pasta containing isoflavones ameriorates gastric emptying time in diabetic patients. 49
Painful constipation: a neglected entity? 48
Isoflavones in Soy-Germ Pasta Modulate the Expression of Human Gastric Genes Involved in Mucosal Defense 48
Duodenal submucosal tunnelization by fishbone 47
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 47
NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver. 46
Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma. 44
Colon and gastric metastases from a primary signet-ring cell carcinoma of the urinary bladder. 43
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 43
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders 43
Soy extract diet in rats to decrease liver steatosis induced by lieber-de carli modified diet 42
A pilot study with all-trans retinoic acid plus tamoxifen and vitamin E in patients with hepatocellular carcinoma (HCC): a four years follow-up 42
NCX-999, a NO-releasing derivative of UDCA, modulates hepatic stellate cells and reduces vasomotor response to nor-epinefrine in intact rats 41
Oral anticoagulants and small intestinal bacterial overgrowth. 40
The identification of farnesoid X receptor modulators as treatment options for non-alcoholic fatty liver disease 40
Bile Acid Signaling in Inflammatory Bowel Diseases 39
Epidemiological features and disease-related concerns of a large cohort of Italian patients with active Crohn's disease 31
Treatment strategy of hepatocellular carcinoma: Comparison between percutaneous ethanol injection and radiofrequency ablation. A three-year follow-up study 29
Small intestinal bacterial overgrowth and warfarin dose requirement variability. 25
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease 9
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 6
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 4
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame 4
Totale 1.979
Categoria #
all - tutte 8.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 0 0 0 0 0 2 19 3 25 24 8 18
2020/2021363 4 26 23 26 83 38 20 5 36 23 26 53
2021/2022341 12 55 8 32 6 4 7 106 4 12 41 54
2022/2023567 37 114 5 61 46 48 0 25 203 1 21 6
2023/2024178 15 19 10 9 1 2 33 10 10 6 24 39
2024/2025216 2 43 15 33 63 60 0 0 0 0 0 0
Totale 1.979